AR069875A1 - Composiciones de temazepam para tabletas de desintegracion oral y metodo de preparacion - Google Patents
Composiciones de temazepam para tabletas de desintegracion oral y metodo de preparacionInfo
- Publication number
- AR069875A1 AR069875A1 ARP080105625A ARP080105625A AR069875A1 AR 069875 A1 AR069875 A1 AR 069875A1 AR P080105625 A ARP080105625 A AR P080105625A AR P080105625 A ARP080105625 A AR P080105625A AR 069875 A1 AR069875 A1 AR 069875A1
- Authority
- AR
- Argentina
- Prior art keywords
- temazepam
- compositions
- preparation
- oral disintegration
- disintegration tablets
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Abstract
Composiciones para tabletas de desintegracion oral que comprenden una cantidad eficaz para uso terapéutico, como por ejemplo, un trastorno del sueno, disfagia, de al menos una droga tal como temazepam, 0,5-3% de un polímero aglutinante para ODT, un alcohol de azucar y/o sacárido y un desintegrante.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1593107P | 2007-12-21 | 2007-12-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR069875A1 true AR069875A1 (es) | 2010-02-24 |
Family
ID=40798736
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP080105625A AR069875A1 (es) | 2007-12-21 | 2008-12-19 | Composiciones de temazepam para tabletas de desintegracion oral y metodo de preparacion |
Country Status (10)
Country | Link |
---|---|
US (1) | US20090169620A1 (es) |
KR (1) | KR20100103844A (es) |
CN (2) | CN101925349A (es) |
AR (1) | AR069875A1 (es) |
BR (1) | BRPI0821761A2 (es) |
CL (1) | CL2008003827A1 (es) |
CO (1) | CO6280465A2 (es) |
CR (1) | CR11581A (es) |
RU (2) | RU2524638C2 (es) |
WO (1) | WO2009086046A1 (es) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
EP2328558A2 (en) * | 2008-08-08 | 2011-06-08 | McNeil-PPC, Inc. | Use of sucralose as a granulating agent |
US8481554B2 (en) | 2009-05-27 | 2013-07-09 | Hetero Research Foundation | Solid oral dosage forms of lamivudine |
US20110097401A1 (en) | 2009-06-12 | 2011-04-28 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
LT3403654T (lt) * | 2009-10-01 | 2019-09-10 | Adare Development I, L.P. | Geriamosios kortikosteroido kompozicijos |
CA2949127C (en) * | 2009-11-10 | 2019-04-09 | North-West University | Method for increasing the solubility of a transcriptase inhibitor composition |
BR112012012999A2 (pt) | 2009-11-30 | 2019-04-02 | Aptalis Pharmatech Inc | Composição farmacêutica, e composição de tablete de desintegração oral (odt) outablete de dispersão rápida (rdt) |
SI2563329T1 (sl) * | 2010-04-27 | 2017-05-31 | Bayer Intellectual Property Gmbh | Oralno razgradljiva tableta, ki vsebuje akarbozo |
AU2011336300B2 (en) * | 2010-12-02 | 2015-05-21 | Adare Pharmaceuticals, Inc. | Rapidly dispersing granules, orally disintegrating tablets and methods |
AU2012250862B2 (en) * | 2011-05-02 | 2015-07-09 | Adare Pharmaceuticals, Inc. | Rapid dissolve tablet compositions for vaginal administration |
KR101285008B1 (ko) * | 2012-04-18 | 2013-07-10 | 제일약품주식회사 | 저용량 엔테카비어의 경구투여 제제의 제조방법 |
CN102784126A (zh) * | 2012-08-23 | 2012-11-21 | 海南卫康制药(潜山)有限公司 | 利福平组合物冻干口腔崩解片及其制备方法 |
CN102784117A (zh) * | 2012-08-23 | 2012-11-21 | 海南卫康制药(潜山)有限公司 | 硫酸庆大霉素组合物冻干口腔崩解片及其制备方法 |
CN102784121A (zh) * | 2012-08-23 | 2012-11-21 | 海南卫康制药(潜山)有限公司 | 左氧氟沙星组合物冻干口腔崩解片及其制备方法 |
WO2015034678A2 (en) | 2013-09-06 | 2015-03-12 | Aptalis Pharmatech, Inc. | Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis |
GR1008992B (el) * | 2015-12-17 | 2017-03-23 | Verisfield (Uk) Ltd, Υποκαταστημα Ελλαδας, Εμπορια Φαρμακων | Φαρμακευτικη συνθεση σε μορφη κοκκιων για χορηγηση απο το στομα που περιεχει μετρονιδαζολη ή παραγωγα αυτης και εναν παραγοντα καλυψης της γευσης |
TWI777515B (zh) | 2016-08-18 | 2022-09-11 | 美商愛戴爾製藥股份有限公司 | 治療嗜伊紅性食道炎之方法 |
US20180256515A1 (en) | 2017-03-10 | 2018-09-13 | Adare Pharmaceuticals, Inc. | Oral amphetamine composition |
US11638698B2 (en) | 2017-04-20 | 2023-05-02 | Zeenar Enterprises Pty Ltd | Liquid crystalline dosage form for administering a statin |
BR112020015316A2 (pt) | 2018-01-30 | 2020-12-08 | Apnimed, Inc. (Delaware) | Métodos e composições para o tratamento da apneia do sono |
CN110840850B (zh) * | 2018-07-24 | 2023-03-17 | 烟台药物研究所 | 一种高生物利用度的塞来昔布冻干口崩片及其制备方法 |
CA3117606A1 (en) * | 2018-10-25 | 2020-04-30 | Zeenar Enterprises Pty Ltd | Composition that forms liquid crystalline particles |
SG11202108225QA (en) * | 2019-02-08 | 2021-08-30 | Brigham & Womens Hospital Inc | Methods and compositions for treating sleep apnea |
FR3099881B1 (fr) | 2019-08-13 | 2022-08-26 | Ethypharm Sa | Comprimé orodispersible d’opioide à faible dosage et son procédé de préparation. |
CN110742868A (zh) * | 2019-11-20 | 2020-02-04 | 合肥拓锐生物科技有限公司 | 一种Mirogabalin Besilate口腔崩解片 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4662880A (en) * | 1986-03-14 | 1987-05-05 | Alza Corporation | Pseudoephedrine, brompheniramine therapy |
US5629310A (en) * | 1986-09-23 | 1997-05-13 | Sterling; William R. | Low dose temazepam |
ES2274625T3 (es) * | 1998-05-18 | 2007-05-16 | Takeda Pharmaceutical Company Limited | Comprimidos desintegrables en la boca que comprenden un bencimidazol. |
WO2004100857A2 (en) * | 2003-05-07 | 2004-11-25 | Akina, Inc. | Highly plastic granules for making fast melting tablets |
GB0420016D0 (en) * | 2004-09-09 | 2004-10-13 | Leuven K U Res & Dev | Controlled release oral delivery system |
US20060105038A1 (en) * | 2004-11-12 | 2006-05-18 | Eurand Pharmaceuticals Limited | Taste-masked pharmaceutical compositions prepared by coacervation |
US20070082048A1 (en) * | 2005-06-08 | 2007-04-12 | Ronald Warner | Sleep aid formulations |
KR101413613B1 (ko) * | 2006-01-27 | 2014-07-10 | 앱탈리스 파마테크, 인코포레이티드 | 약 염기성 선택성 세로토닌 5-ht3 차단제와 유기산을 포함하는 약물 전달 시스템 |
-
2008
- 2008-12-19 BR BRPI0821761-0A patent/BRPI0821761A2/pt not_active IP Right Cessation
- 2008-12-19 RU RU2010130340/15A patent/RU2524638C2/ru not_active IP Right Cessation
- 2008-12-19 CN CN2008801252464A patent/CN101925349A/zh active Pending
- 2008-12-19 AR ARP080105625A patent/AR069875A1/es unknown
- 2008-12-19 US US12/339,908 patent/US20090169620A1/en not_active Abandoned
- 2008-12-19 KR KR1020107016364A patent/KR20100103844A/ko active IP Right Grant
- 2008-12-19 WO PCT/US2008/087583 patent/WO2009086046A1/en active Application Filing
- 2008-12-19 CL CL2008003827A patent/CL2008003827A1/es unknown
- 2008-12-19 CN CN201510958509.1A patent/CN105496978A/zh active Pending
-
2010
- 2010-07-16 CO CO10087094A patent/CO6280465A2/es not_active Application Discontinuation
- 2010-07-21 CR CR11581A patent/CR11581A/es not_active Application Discontinuation
-
2014
- 2014-02-24 RU RU2014106871/15A patent/RU2014106871A/ru not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
BRPI0821761A2 (pt) | 2015-06-16 |
KR20100103844A (ko) | 2010-09-28 |
CN105496978A (zh) | 2016-04-20 |
RU2524638C2 (ru) | 2014-07-27 |
CO6280465A2 (es) | 2011-05-20 |
RU2010130340A (ru) | 2012-01-27 |
WO2009086046A1 (en) | 2009-07-09 |
US20090169620A1 (en) | 2009-07-02 |
CN101925349A (zh) | 2010-12-22 |
RU2014106871A (ru) | 2015-08-27 |
CL2008003827A1 (es) | 2009-07-24 |
CR11581A (es) | 2010-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR069875A1 (es) | Composiciones de temazepam para tabletas de desintegracion oral y metodo de preparacion | |
UY31205A1 (es) | Composiciones de tabletas de desintegracion oral de lamotrigina | |
CL2013001586A1 (es) | Composicion microgranular de rapida dispersion que comprende al menos un alcohol de azucar, un sacarido, o una mezcla de estos, al menos un super disgregante y al menos un aditivo multifuncion; comprimido de desintegracion oral que comprende la composicion microgranular y al menos un principio activo; y metodos de fabricacion. | |
CL2011000935A1 (es) | Composicion farmaceutica que comprende acetaminofeno y un material de tramadol complejo, que exhibe una liberacion sostenida y coordinada a traves de una capa de liberacion sostenida y otra de liberacion inmediata; metodo de preparacion;y el uso de un material complejo de tramadol y acetaminofeno para preparar un medicamento para el tratamiento del dolor. | |
MX2010005931A (es) | Profarmacos de tetrahidrocanabinol, composiciones que comprenden profarmacos de tetrahidrocanabinol y metodos para utilizar los mismos. | |
MX2010004323A (es) | Formas de dosificacion oral que comprenden acetato de licarbazepina. | |
MX343358B (es) | Tabletas de acetato de ulipristal. | |
CL2008001002A1 (es) | Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana. | |
UY33062A (es) | Comprimidos y composiciones farmacéuticas comprimibles recubiertos y métodos de fabricación | |
CL2008001003A1 (es) | Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana. | |
GT200600445A (es) | Formas de presentación farmaceuticas solidas de administración oral con liberacion rapida del principio activo. | |
NZ594022A (en) | Pharmaceutical composition comprising linagliptin and optionally a sglt2 inhibitor, and uses thereof | |
CR20110110A (es) | Composicion farmaceutica | |
ATE540680T1 (de) | Pharmazeutische aripiprazol-zusammensetzungen | |
BRPI0814666A2 (pt) | composição farmacêutica para a administração oral, uso de uma formulação. processo para a preparação de uma forma de dosagem sólida, e, forma de dosagem sólida | |
CL2012000319A1 (es) | Uso de una composición farmaceutica que comprende treprostinil para la preparación de un medicamento para el tratamiento o la prevención de una afección asociada a la fibrosis quística. | |
AR086249A1 (es) | Composiciones de tabletas de disolucion rapida de administracion vaginal | |
CL2007002875A1 (es) | Composicion farmaceutica recubierta por una pelicula que comprende capecitabina y al menos un disgregante, util en el tratamiento del cancer para pacientes que tienen dificultad para tragar las formas de dosificacion solidas orales. | |
CR11744A (es) | Formulacion liquida para deferiprona con gusto agradable al paladar | |
BR112012003280A2 (pt) | composição farmacêutica para administração oral, método para tratar uma doença, uso do composto, e, composto. | |
AR089509A1 (es) | Metodo para tratar la perdida osea alveolar, un implante dental, un anticuerpo antiesclerostina, un gel o matriz que comprende dicho anticuerpo y uso | |
MX2012013021A (es) | Formulaciones resistentes a alcohol. | |
WO2010127205A3 (en) | Fixed dose drug combination formulations | |
CL2009001841A1 (es) | Uso de una composición de liberación sostenida de 4-aminopiridina para preparar un medicamento útil para tratar esclerosis multiple en un sujeto. | |
AR070392A1 (es) | Composiciones de tabletas de ranitidina de desintegracion oral y sus metodos de eleboracion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |